1. Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing
   Chan Gyu Lee et al, 2021, Front. Pharmacol. CrossRef
2. Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?
   Bernd Kaina, 0 CrossRef